A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis

Abstract BackgroundThe integration of wearable technology for heart rate monitoring offers potential advancements in managing hyperthyroidism by providing a feasible way to track thyroid function. Although digital health solutions are gaining traction in various chronic condit...

Full description

Saved in:
Bibliographic Details
Main Authors: Jung Hyun Kim, Jaeyong Shin, Man S Kim, Jae Hoon Moon
Format: Article
Language:English
Published: JMIR Publications 2025-07-01
Series:JMIR mHealth and uHealth
Online Access:https://mhealth.jmir.org/2025/1/e56738
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849728951948148736
author Jung Hyun Kim
Jaeyong Shin
Man S Kim
Jae Hoon Moon
author_facet Jung Hyun Kim
Jaeyong Shin
Man S Kim
Jae Hoon Moon
author_sort Jung Hyun Kim
collection DOAJ
description Abstract BackgroundThe integration of wearable technology for heart rate monitoring offers potential advancements in managing hyperthyroidism by providing a feasible way to track thyroid function. Although digital health solutions are gaining traction in various chronic conditions, their cost-effectiveness in hyperthyroidism management requires deeper investigation. ObjectiveThis study aimed to evaluate the cost-effectiveness of a wearable or mobile-based thyroid function digital monitoring solution for hyperthyroidism management and to make a comparison with the existing standard approach within the South Korean health care context. MethodsWe developed a decision-analytic Markov microsimulation model to simulate the cost and effectiveness of digital monitoring in a cohort of 10,000 hypothetical hyperthyroidism patients aged 40 years. The analysis was conducted from the perspective of the health care system, with a 4.5% annual discount rate applied to costs and effectiveness and an inflation adjustment to 2022 values. Model inputs were sourced from clinical studies, publicly available datasets, and expert input, with outcomes measured in quality-adjusted life years (QALYs). Cost-effectiveness was evaluated through incremental cost-effectiveness ratios (ICERs) and net monetary benefits (NMB), with additional deterministic and probabilistic sensitivity analyses performed to address input uncertainties. ResultsIntegrating digital monitoring yielded an additional 0.32 QALYs per patient at an incremental cost of US $3143, resulting in an ICER of US $9804.30 per QALY, significantly below the South Korean willingness-to-pay threshold of US $32,255/QALY. The digitally supported group exhibited improved rates of long-term remission (22.68%, 2268/10,000) and reduced postremission relapse (17.87%, 1787/10,000) compared to standard care (17.48%, 1748/10,000 and 26.37%, 2637/10,000, respectively). Probabilistic sensitivity analysis showed that digital intervention was the preferred cost-effective strategy in 64.4% (6440/10,000) of iterations. Subscription costs of the digital platform and the utility weight for thyroid-associated orbitopathy emerged as key factors affecting the ICER in sensitivity analyses. ConclusionsThe findings suggest that digital monitoring provides a cost-effective strategy for enhancing hyperthyroidism management, supporting sustained remission, and reducing relapse rates. As such, digital solutions could serve as a valuable adjunct to traditional care, with the cost-effectiveness analysis providing an economic basis for determining pricing and value-based reimbursement in health care systems. The study underscores the importance of integrating digital solutions in chronic disease management and suggests that further research should include societal costs, such as productivity, to capture economic benefits fully.
format Article
id doaj-art-d709771b1d7d4e968d582cbffe2dc9de
institution DOAJ
issn 2291-5222
language English
publishDate 2025-07-01
publisher JMIR Publications
record_format Article
series JMIR mHealth and uHealth
spelling doaj-art-d709771b1d7d4e968d582cbffe2dc9de2025-08-20T03:09:24ZengJMIR PublicationsJMIR mHealth and uHealth2291-52222025-07-0113e56738e5673810.2196/56738A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness AnalysisJung Hyun Kimhttp://orcid.org/0000-0003-4248-3760Jaeyong Shinhttp://orcid.org/0000-0002-2955-6382Man S Kimhttp://orcid.org/0000-0002-1507-9829Jae Hoon Moonhttp://orcid.org/0000-0001-6327-0575 Abstract BackgroundThe integration of wearable technology for heart rate monitoring offers potential advancements in managing hyperthyroidism by providing a feasible way to track thyroid function. Although digital health solutions are gaining traction in various chronic conditions, their cost-effectiveness in hyperthyroidism management requires deeper investigation. ObjectiveThis study aimed to evaluate the cost-effectiveness of a wearable or mobile-based thyroid function digital monitoring solution for hyperthyroidism management and to make a comparison with the existing standard approach within the South Korean health care context. MethodsWe developed a decision-analytic Markov microsimulation model to simulate the cost and effectiveness of digital monitoring in a cohort of 10,000 hypothetical hyperthyroidism patients aged 40 years. The analysis was conducted from the perspective of the health care system, with a 4.5% annual discount rate applied to costs and effectiveness and an inflation adjustment to 2022 values. Model inputs were sourced from clinical studies, publicly available datasets, and expert input, with outcomes measured in quality-adjusted life years (QALYs). Cost-effectiveness was evaluated through incremental cost-effectiveness ratios (ICERs) and net monetary benefits (NMB), with additional deterministic and probabilistic sensitivity analyses performed to address input uncertainties. ResultsIntegrating digital monitoring yielded an additional 0.32 QALYs per patient at an incremental cost of US $3143, resulting in an ICER of US $9804.30 per QALY, significantly below the South Korean willingness-to-pay threshold of US $32,255/QALY. The digitally supported group exhibited improved rates of long-term remission (22.68%, 2268/10,000) and reduced postremission relapse (17.87%, 1787/10,000) compared to standard care (17.48%, 1748/10,000 and 26.37%, 2637/10,000, respectively). Probabilistic sensitivity analysis showed that digital intervention was the preferred cost-effective strategy in 64.4% (6440/10,000) of iterations. Subscription costs of the digital platform and the utility weight for thyroid-associated orbitopathy emerged as key factors affecting the ICER in sensitivity analyses. ConclusionsThe findings suggest that digital monitoring provides a cost-effective strategy for enhancing hyperthyroidism management, supporting sustained remission, and reducing relapse rates. As such, digital solutions could serve as a valuable adjunct to traditional care, with the cost-effectiveness analysis providing an economic basis for determining pricing and value-based reimbursement in health care systems. The study underscores the importance of integrating digital solutions in chronic disease management and suggests that further research should include societal costs, such as productivity, to capture economic benefits fully.https://mhealth.jmir.org/2025/1/e56738
spellingShingle Jung Hyun Kim
Jaeyong Shin
Man S Kim
Jae Hoon Moon
A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
JMIR mHealth and uHealth
title A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
title_full A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
title_fullStr A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
title_full_unstemmed A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
title_short A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
title_sort digital software support platform for hyperthyroidism management in south korea markov simulation model based cost effectiveness analysis
url https://mhealth.jmir.org/2025/1/e56738
work_keys_str_mv AT junghyunkim adigitalsoftwaresupportplatformforhyperthyroidismmanagementinsouthkoreamarkovsimulationmodelbasedcosteffectivenessanalysis
AT jaeyongshin adigitalsoftwaresupportplatformforhyperthyroidismmanagementinsouthkoreamarkovsimulationmodelbasedcosteffectivenessanalysis
AT manskim adigitalsoftwaresupportplatformforhyperthyroidismmanagementinsouthkoreamarkovsimulationmodelbasedcosteffectivenessanalysis
AT jaehoonmoon adigitalsoftwaresupportplatformforhyperthyroidismmanagementinsouthkoreamarkovsimulationmodelbasedcosteffectivenessanalysis
AT junghyunkim digitalsoftwaresupportplatformforhyperthyroidismmanagementinsouthkoreamarkovsimulationmodelbasedcosteffectivenessanalysis
AT jaeyongshin digitalsoftwaresupportplatformforhyperthyroidismmanagementinsouthkoreamarkovsimulationmodelbasedcosteffectivenessanalysis
AT manskim digitalsoftwaresupportplatformforhyperthyroidismmanagementinsouthkoreamarkovsimulationmodelbasedcosteffectivenessanalysis
AT jaehoonmoon digitalsoftwaresupportplatformforhyperthyroidismmanagementinsouthkoreamarkovsimulationmodelbasedcosteffectivenessanalysis